Literature DB >> 6827872

Measuring functional outcomes in chronic disease: a comparison of traditional scales and a self-administered health status questionnaire in patients with rheumatoid arthritis.

R A Deyo, T S Inui, J D Leininger, S S Overman.   

Abstract

A new "health-status" questionnaire, the Sickness Impact Profile (SIP), was examined to determine whether it offered measurement advantages over the traditional American Rheumatism Association (ARA) functional scale or patient self-ratings of function. Seventy-nine outpatients with rheumatoid arthritis (RA) administered the SIP to themselves and provided self-ratings on a 7-point functional scale. Clinicians independently rated patients on the ARA functional scale, and repeated measures were obtained over a 6-month period. Scores on the SIP or its subscales showed stronger correlations than the other scales with hematocrit, sedimentation rate, grip strength, morning stiffness, duration of RA, anatomic stage, work status, and psychiatric status. Validity of the SIP appeared to be maintained with repeated administrations, and the SIP was more reliable than either of the other scales. These findings, as well as the comprehensiveness and feasibility of the self-administered SIP, suggest that this (and perhaps similar health status instruments) may be a useful supplement to more traditional measures of chronic disease outcome.

Entities:  

Mesh:

Year:  1983        PMID: 6827872     DOI: 10.1097/00005650-198302000-00006

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  22 in total

Review 1.  A comparative review of generic quality-of-life instruments.

Authors:  S J Coons; S Rao; D L Keininger; R D Hays
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

2.  Reassessing quality-of-life instruments in the evaluation of new drugs.

Authors:  G H Guyatt; R J Jaeschke
Journal:  Pharmacoeconomics       Date:  1997-12       Impact factor: 4.981

3.  The SIP68: an abbreviated sickness impact profile for disability outcomes research.

Authors:  Upasana Nanda; Patricia M McLendon; Elena M Andresen; Eric Armbrecht
Journal:  Qual Life Res       Date:  2003-08       Impact factor: 4.147

Review 4.  Health-related quality of life measurement in pharmaceutical care. Targeting an outcome that matters.

Authors:  Nadir M Kheir; J W Foppe van Mil; John P Shaw; Janie L Sheridan
Journal:  Pharm World Sci       Date:  2004-06

Review 5.  A review of the progress towards developing health-related quality-of-life instruments for international clinical studies and outcomes research.

Authors:  R T Anderson; N K Aaronson; M Bullinger; W L McBee
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

Review 6.  Measuring health status? A review of the sickness impact and functional limitations profiles.

Authors:  S J Williams
Journal:  Health Care Anal       Date:  1996-11

7.  The usefulness of the Functional Status Questionnaire and Medical Outcomes Study Short Form in Parkinson's disease research.

Authors:  L M Rubenstein; M D Voelker; E A Chrischilles; D C Glenn; R B Wallace; R L Rodnitzky
Journal:  Qual Life Res       Date:  1998-05       Impact factor: 4.147

8.  The Veterans Administration Northwest Regional Health Services Research and Development Field Program: organization, activities, and early outcomes.

Authors:  C D Austin; W B Carter; M L Durham; S C Hedrick; D H Hickam; T S Inui; T D Koepsell; R A Pearlman; M D Petersen; M L Rothman
Journal:  Health Serv Res       Date:  1986-02       Impact factor: 3.402

9.  Components of health: an analysis in rheumatoid arthritis using quality of life questionnaires and clinical and laboratory variables.

Authors:  M Borstlap; M van de Laar; J Zant; J van der Korst
Journal:  Ann Rheum Dis       Date:  1993-09       Impact factor: 19.103

Review 10.  Review of available instruments and methods for assessing quality of life in anti-anginal trials.

Authors:  B D Bliven; C P Green; J A Spertus
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.